Amniotic Membrane Market

Amniotic membrane is a combination of tissues and cells which helps in wound healing by acting as foundation for re-growth of soft tissues. These are most widely used in eye surgery as a biological bandage to heal or replace damaged eye tissue. Increasing aging patient population, the rise in amniotic membrane-based transplantations globally, and rising disease awareness drive the growth of the global amniotic membrane market. However, stringent regulatory policies may hamper the growth of the market.

The global amniotic membrane market is expected to register a CAGR of 12.16% during the forecast period from 2018 to 2023. In 2017, the market was led by the Americas with 37.6% share, followed by Europe and Asia-Pacific with shares of 31.9% and 23.4%, respectively.

The global amniotic membrane market has been segmented based on the type, application, end user, and region.

Based on the type, the cryopreservation amniotic membrane segment accounted for the largest market share of 56.5% in 2017, with a market value of USD 609.44 million, which is projected to register a CAGR of 10.44% during the forecast period.

Based on application, the surgical wounds segment accounted for the largest market share of 21.8% in 2017, with a market value of USD 235.58 million, which is projected to register a CAGR of 12.47% during the forecast period.

Based on end user, the hospital & clinics segment accounted for the largest market share of 38.9% in 2017, with a market value of USD 420.25 million, which is projected to register a CAGR of 13.39% during the forecast period.